Ask AI
ProCE Banner Activity

Novel Anti-HER2–Targeted Tyrosine Kinase Inhibitors

Slideset Download
Download this slideset on newer TKIs for relapsed or refractory HER2-positive metastatic breast cancer.

Released: May 29, 2020

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

Cristina Saura Manich, MD, PhD

Head, Breast Cancer Unit
Medical Oncology Service
Vall d’Hebron University Hospital
Breast Cancer Program, Vall d’Hebron Institute of Oncology (VHIO)
Barcelona, Spain